Cited by 1,086Alzheimer's disease research and treatmentsDementia and Cognitive Impairment ResearchPrion Diseases and Protein Misfolding

The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.

A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease.

Open access

Hensley, K, Carney, J M, Mattson, M P, Aksenova, M, Harris, M, Wu, J F, Floyd, R A, Butterfield, D A·1994·Proceedings of the National Academy of Sciences

DOI 10.1073/pnas.91.8.3270PMC PMC43558

Open this paper in CoChat — free account

Abstract

beta-Amyloid is a 39- to 43-amino-acid neurotoxic peptide that aggregates to form the core of Alzheimer disease-associated senile (amyloid) plaques. No satisfactory hypothesis has yet been proposed to explain the mechanism of beta-amyloid aggregation and toxicity. We present mass spectrometric and electron paramagnetic resonance spin trapping evidence that beta-amyloid, in aqueous solution, fragments and generates free radical peptides. beta-Amyloid fragments, at concentrations that previously have been shown to be neurotoxic to cultured neurons, can inactivate oxidation-sensitive glutamine synthetase and creatine kinase enzymes. Also, salicylate hydroxylation assays indicate that reactive oxygen species are generated by the beta-amyloid-(25-35) fragment during cell-free incubation. These results are formulated into a free radical-based unifying hypothesis for neurotoxicity of beta-amyloid and are discussed with reference to membrane molecular alterations in Alzheimer disease.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1073/pnas.91.8.3270

Cites

23 of 23 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor
Kang, J., Lemaire, H.-G., Unterbeck, A., Salbaum, J. M., Masters, C. L., Grzeschik, K.-H., Multhaup, G., Beyreuther, K., & Müller-Hill, B. (1987) · Nature · doi:10.1038/325733a0 · Cited by 4,619
The molecular pathology of Alzheimer's disease
Selkoe, D. J. (1991) · Neuron · doi:10.1016/0896-6273(91)90052-2 · Cited by 2,708
Neurotrophic and Neurotoxic Effects of Amyloid β Protein: Reversal by Tachykinin Neuropeptides
Yankner, B. A., Duffy, L. K., & Kirschner, D. A. (1990) · Science · doi:10.1126/science.2218531 · Cited by 1,975
Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state
Pike, C., Burdick, D., Walencewicz, A., Glabe, C., & Cotman, C. (1993) · The Journal of Neuroscience · doi:10.1523/jneurosci.13-04-01676.1993 · Cited by 1,417
Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease.
Smith, C. D., Carney, J. M., Starke-Reed, P. E., Oliver, C. N., Stadtman, E. R., Floyd, R. A., & Markesbery, W. R. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.23.10540 · Cited by 1,296
Self-citation
Assembly and aggregation properties of synthetic Alzheimer's A4/beta amyloid peptide analogs.
Burdick, D., Soreghan, B., Kwon, M., Kosmoski, J., Knauer, M., Henschen, A., Yates, J., Cotman, C., & Glabe, C. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)48529-8 · Cited by 1,014
Oxidative damage to brain proteins, loss of glutamine synthetase activity, and production of free radicals during ischemia/reperfusion-induced injury to gerbil brain.
Oliver, C., Starke-Reed, P. E., Stadtman, E. R., Liu, G. J., Carney, J. M., & Floyd, R. A. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.13.5144 · Cited by 771
Self-citation
Reversal of age-related increase in brain protein oxidation, decrease in enzyme activity, and loss in temporal and spatial memory by chronic administration of the spin-trapping compound N-tert-butyl-alpha-phenylnitrone.
Carney, J. M., Starke-Reed, P. E., Oliver, C., Landum, R. W., Cheng, M. S., Wu, J., & Floyd, R. A. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.9.3633 · Cited by 724
Self-citation
Free radical damage to protein and DNA: Mechanisms involved and relevant observations on brain undergoing oxidative stress
Floyd, R. A., & Carney, J. M. (1992) · Annals of Neurology · doi:10.1002/ana.410320706 · Cited by 539
Self-citation
β-Amyloid precursor protein metabolites and loss of neuronal Ca2+ homeostasis in Alzheimer's disease
Mattson, M. P., Barger, S. W., Cheng, B., Lieberburg, I. M., Smith‐Swintosky, V. L., & Rydel, R. E. (1993) · Trends in Neurosciences · doi:10.1016/0166-2236(93)90009-b · Cited by 518
Self-citation

Flagged first, then by citations

Show all 23 references

Research works printed but not linked: 5

[9]Oliver, C. N., Starke-Reed, P. E., Stadtman, E. R., Liu, G. J., Carney, J. M. & Floyd, R. A. (1990) Proc. Natl. Acad. Sci. USA 87, 5144–5147.
[11]Miller, R. E., Hadenberg, R. & Gersham, H. (1978) Proc. Natl. Acad. Sci. USA 75, 1418–1422.
[13]Janzen, E. G. (1980) in Free Radicals in Biology, ed. Pryor, W. A. (Academic, New York), Vol. 4, pp. 115-154.
[19]Carney, J. M., Starke-Reed, P. E., Oliver, C. N., Landum, R. W., Cheng, M. S., Wu, J. F. & Floyd, R. A. (1991) Proc. Natl. Acad. Sci. USA 88, 3633–3636.
[27]Smith, C. D., Carney, J. M., Starke-Reed, P. E., Oliver, C. N., Stadtman, E. R., Floyd, R. A. & Markesbery, W. R. (1991) Proc. Natl. Acad. Sci. USA 88, 10540–10543.

Sorted by citations

Items 501–600 of 1,000

Copper/zinc superoxide dismutase overexpression promotes survival of cortical neurons exposed to neurotoxins in vitro
Borg, J., & London, J. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10404 · Cited by 53
Metallothionein-III Inhibits Initial Neurite Formation in Developing Neurons as Well as Postinjury, Regenerative Neurite Sprouting
Chung, R. S., Vickers, J. C., Chuah, M. I., Eckhardt, B. L., & West, A. K. (2002) · Experimental Neurology · doi:10.1006/exnr.2002.8017 · Cited by 53
Amyloid Precursor Protein Family-induced Neuronal Death Is Mediated by Impairment of the Neuroprotective Calcium/Calmodulin Protein Kinase IV-dependent Signaling Pathway
Mbebi, C., Sée, V., Mercken, L., Pradier, L., Müller, U., & Loeffler, J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m107948200 · Cited by 53
Chalcone Derivatives with a High Potential as Multifunctional Antioxidant Neuroprotectors
Pérez‐González, A., Castañeda‐Arriaga, R., Guzmán‐López, E. G., Hernández‐Ayala, L. F., & Galano, A. (2022) · ACS Omega · doi:10.1021/acsomega.2c05518 · Cited by 54
Emerging role of antioxidants in Alzheimer's disease: Insight into physiological, pathological mechanisms and management
Kamaljeet, Singh, S., Gupta, G. D., & Aran, K. R. (2023) · Pharmaceutical Science Advances · doi:10.1016/j.pscia.2023.100021 · Cited by 52
Pharmacologists and Alzheimer disease therapy: to boldly go where no scientist has gone before
Mancuso, C., Siciliano, R., Barone, E., Butterfield, D. A., & Preziosi, P. (2011) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2011.601740 · Cited by 53
Self-citation
Biliverdin reductase-A impairment links brain insulin resistance with increased Aβ production in an animal model of aging: Implications for Alzheimer disease
Triani, F., Tramutola, A., Domenico, F. D., Sharma, N. K., Butterfield, D. A., Head, E., Marzia Perluigi, A., & Barone, E. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.07.005 · Cited by 53
Self-citation
Effect of Phenolic Compounds Against Aβ Aggregation and Aβ-Induced Toxicity in Transgenic C. elegans
Jagota, S., & Rajadas, J. (2011) · Neurochemical Research · doi:10.1007/s11064-011-0580-5 · Cited by 52
A quantum chemical study on the free radical scavenging activity of tyrosol and hydroxytyrosol
Galano, A., Alvarez-Idaboy, J. R., Francisco‐Márquez, M., & Medina, M. E. (2012) · Theoretical Chemistry Accounts · doi:10.1007/s00214-012-1173-3 · Cited by 52
RIFAMPICIN: An antibiotic with brain protective function
Yuluğ, B., Hanoğlu, L., Kılıç, E., & Schabitz, W. R. (2014) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2014.05.007 · Cited by 51
Neuropeptide Y Protects Rat Cortical Neurons against β-Amyloid Toxicity and Re-establishes Synthesis and Release of Nerve Growth Factor
Croce, N., Ciotti, M. T., Gelfo, F., Cortelli, S., Federici, G., Caltagirone, C., Bernardini, S., & Angelucci, F. (2012) · ACS Chemical Neuroscience · doi:10.1021/cn200127e · Cited by 50
The E646D-ATP13A4 Mutation Associated with Autism Reveals a Defect in Calcium Regulation
Vallipuram, J., Grenville, J., & Crawford, D. A. (2009) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-009-9445-8 · Cited by 50
Pro‐apoptotic signaling in neuronal cells following iron and amyloid beta peptide neurotoxicity
Kuperstein, F., & Yavin, E. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01831.x · Cited by 50
Pyruvate protection against β‐amyloid‐induced neuronal death: Role of mitochondrial redox state
Alvarez, G., Ramos, M., Ruiz, F. H., Satrústegui, J., & Bogónez, E. (2003) · Journal of Neuroscience Research · doi:10.1002/jnr.10648 · Cited by 50
Quantum-chemical Calculations of the Antioxidant Properties of trans-p-coumaric Acid and trans-sinapinic Acid
Urbaniak, A. J., Molski, M., & Szeląg, M. (2012) · Computational Methods in Science and Technology · doi:10.12921/cmst.2012.18.02.117-128 · Cited by 50
Alzheimer's β-amyloid peptide as a source of neurotoxic free radicals: the role of structural effects
Pogocki, D. (2003) · Acta Neurobiologiae Experimentalis · doi:10.55782/ane-2003-1463 · Cited by 50
The Role of G Protein Activation in the Toxicity of Amyloidogenic Aβ-(1–40), Aβ-(25–35), and Bovine Calcitonin
Rymer, D. L., & Good, T. A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m005800200 · Cited by 50
Different expression of calreticulin and immunoglobulin binding protein in Alzheimer's disease brain
Taguchi, J., Fujii, A., Fujino, Y., Tsujioka, Y., Takahashi, M., Tsuboi, Y., Wada, I., & Yamada, T. (2000) · Acta Neuropathologica · doi:10.1007/s004019900165 · Cited by 50
In Vivo and In Vitro Effects of an Apolipoprotein E Mimetic Peptide on Amyloid-β Pathology
Handattu, S. P., Monroe, C. E., Nayyar, G., Palgunachari, M. N., Kadish, I., van Groen, T., Anantharamaiah, G. M., & Garber, D. W. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-122377 · Cited by 50
Entorhinal cortical defects in Tg2576 mice are present as early as 2–4 months of age
Duffy, Á., Morales‐Corraliza, J., Bermudez‐Hernandez, K., Schaner, M. J., Magagna‐Poveda, A., Mathews, P. M., & Scharfman, H. E. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.07.001 · Cited by 52
Ameliorative effect of 1,2-benzenedicarboxylic acid dinonyl ester against amyloidbetapeptide-induced neurotoxicity
Choi, S. J., Kim, M. J., Heo, H. J., Kim, J. K., Jun, W. J., Kim, H. K., Kim, E.-K., Kim, M. O., Cho, H. Y., Hwang, H., et al. (2009) · Amyloid · doi:10.1080/13506120802676997 · Cited by 49
Decoding the Role of Platelets and Related MicroRNAs in Aging and Neurodegenerative Disorders
Espinosa‐Parrilla, Y., González-Billault, C. E., Eduardo Fuentes, Q., Palomo, I. F., & Alarcón, M. A. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00151 · Cited by 50
Regulation of the Spatiotemporal Pattern of Expression of the Glutamine Synthetase Gene
Lie‐Venema, H., Hakvoort, T. B. M., van Hemert, F. J., Moorman, A. F. M., & Lamers, W. H. (1998) · Progress in nucleic acid research and molecular biology · doi:10.1016/s0079-6603(08)60829-6 · Cited by 49
Cerebrometabolic abnormalities in Alzheimer's disease
Blass, J. P. (2003) · Neurological Research · doi:10.1179/016164103101201995 · Cited by 49
Targeting ASK1 in ER stress-related neurodegenerative diseases
Homma, K., Katagiri, K., Nishitoh, H., & Ichijo, H. (2009) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728220902980249 · Cited by 49
The Triggering Receptor Expressed on Myeloid Cells 2: “TREM-ming” the Inflammatory Component Associated with Alzheimer's Disease
Rohn, T. T. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/860959 · Cited by 51
Modulation of neurosteroid production in human neuroblastoma cells by Alzheimer's disease key proteins
Schaeffer, V., Patte‐Mensah, C., Eckert, A., & Mensah‐Nyagan, A. G. (2006) · Journal of Neurobiology · doi:10.1002/neu.20267 · Cited by 48
Increased susceptibility to amyloid toxicity in familial Alzheimer's fibroblasts
Cecchi, C., Fiorillo, C., Baglioni, S., Pensalfini, A., Bagnoli, S., Nacmias, B., Sorbi, S., Nosi, D., Relini, A., & Liguri, G. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.05.014 · Cited by 48
Amyloid-β impairs development of neuronal progenitor cells by oxidative mechanisms
Mazur‐Kolecka, B., Golabek, A. A., Nowicki, K., Flory, M. J., & Frackowiak, J. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.07.006 · Cited by 48
The glutamatergic system in Alzheimer’s disease: a systematic review with meta-analysis
Soares, C., Ros, L. U. D., Machado, L. S., da Rocha, A. S., Lazzarotto, G., Carello‐Collar, G., Bastiani, M. A. D., Ferrari‐Souza, J. P., Lussier, F. Z., Souza, D. O., et al. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02473-0 · Cited by 50
The production of hydrogen peroxide during early-stage protein aggregation: a common pathological mechanism in different neurodegenerative diseases?
Tabner, B. J., Turnbull, S., Fullwood, N. J., German, M. J., & Allsop, D. (2005) · Biochemical Society Transactions · doi:10.1042/bst0330548 · Cited by 47
Degenerative and protective signaling mechanisms in the neurofibrillary pathology of AD
Mattson, M. P. (1995) · Neurobiology of Aging · doi:10.1016/0197-4580(94)00182-z · Cited by 47
Self-citation
Understanding the biological activity of amyloid proteins in vitro: From inhibited cellular mtt reduction to altered cellular cholesterol homeostatis
Liu, Y. (1999) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(99)00003-2 · Cited by 47
Effects of amyloid-beta peptides on hydrogen peroxide-metabolizing enzymes in rat brainin vivo
Kaminsky, Y. G., & Kosenko, E. A. (2008) · Free Radical Research · doi:10.1080/10715760802159057 · Cited by 47
Lymphocytes as cell model to study apoptosis in Alzheimer’s disease: vulnerability to programmed cell death appears to be altered
Eckert, A., Cotman, C. W., Zerfaß, R., Hennerici, M. G., & Müller, W. E. G. (1998) · Journal of neural transmission. Supplementum · doi:10.1007/978-3-7091-7508-8_25 · Cited by 47
Free radical formation in autopsy samples of Alzheimer and control cortex
Zhou, Y., Richardson, J. S., Mombourquette, M. J., & Weil, J. A. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(94)11787-j · Cited by 47
Zinc and its effects on oxidative stress in Alzheimer’s disease
Yuan, Y., Niu, F., Liu, Y., & Lu, N. (2014) · Neurological Sciences · doi:10.1007/s10072-014-1668-x · Cited by 47
Modulation of mitochondrial calcium as a pharmacological target for Alzheimer's disease
Hung, C. H.-L., Ho, J. Y. S., & Chang, R. C. (2010) · Ageing Research Reviews · doi:10.1016/j.arr.2010.05.003 · Cited by 46
Copper Enhances Amyloid-β Peptide Neurotoxicity and non β-Aggregation: A Series of Experiments Conducted upon Copper-Bound and Copper-Free Amyloid-β Peptide
Dai, X., Sun, Y., Gao, Z., & Jiang, Z.-F. (2009) · Journal of Molecular Neuroscience · doi:10.1007/s12031-009-9282-8 · Cited by 46
Protective effects of compound FLZ on beta-amyloid peptide-(25-35)-induced mouse hippocampal injury and learning and memory impairment1
Fang, F., & Liu, G.-T. (2006) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2006.00347.x · Cited by 46
The effect of insulin and glucose on the plasma concentration of Alzheimer's amyloid precursor protein
Boyt, A., Taddei, K., Hallmayer, J. F., Helmerhorst, E., Gandy, S., Craft, S., & Martins, R. N. (1999) · Neuroscience · doi:10.1016/s0306-4522(99)00458-3 · Cited by 46
Calretinin-immunoreactive neurons are resistant to β-amyloid toxicity in vitro
Pike, C. J., & Cotman, C. W. (1995) · Brain Research · doi:10.1016/0006-8993(94)01354-k · Cited by 46
Aβ42 and ROS dual-targeted multifunctional nanocomposite for combination therapy of Alzheimer’s disease
Zhang, L., Cao, K., Xie, J., Liang, X., Gong, H., Luo, Q., & Luo, H. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-02543-z · Cited by 48
One-electron oxidation of β-amyloid peptide: sequence modulation of reactivity
Kadlcik, V., Sicard‐Roselli, C., Mattioli, T. A., Kodı́ček, M., & Houée‐Levin, C. (2004) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.06.015 · Cited by 45
Copper/zinc superoxide dismutase expression in the human central nervous system. Correlation with selective neuronal vulnerability.
Bergeron, C., Petrunka, C. N., & Weyer, L. (1996) · PubMed Central · Cited by 45
Chronic oxidative damage together with genome repair deficiency in the neurons is a double whammy for neurodegeneration: Is damage response signaling a potential therapeutic target?
Wang, H., Dharmalingam, P., Vasquez, V., Mitra, J., Boldogh, I. R., Rao, K. S. J., Kent, T. A., MITRA, S. P., & Hegde, M. L. (2016) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2016.09.005 · Cited by 46
Amyloid Beta Peptide VHHQ, KLVFF, and IIGLMVGGVV Domains Involved in Fibrilization: AFM and Electrochemical Characterization
Enache, T. A., Paquim, A.-M. C., & Oliveira‐Brett, A. M. (2018) · Analytical Chemistry · doi:10.1021/acs.analchem.7b04686 · Cited by 44
Possible association between Cys311Ser polymorphism of paraoxonase 2 gene and late-onset Alzheimer's disease in Chinese
Shi, J., Zhang, S., Tang, M., Liu, X., Li, T., Han, H., Wang, Y., Guo, Y., Zhao, J., Li, H., et al. (2004) · Molecular Brain Research · doi:10.1016/j.molbrainres.2003.10.018 · Cited by 44
Oral and subcutaneous administration of the glycosaminoglycan C3 attenuates Aβ(25–35)-induced abnormal tau protein immunoreactivity in rat brain
Dudás, B., Cornelli, U., Lee, J. M., Hejna, M. J., Walzer, M., Lorens, S. A., Mervis, R. F., Fareed, J., & Hanin, I. (2002) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00255-x · Cited by 46
GM1 Inhibits Amyloid β-Protein-Induced Cytokine Release
Ariga, T., & Yu, R. K. (1999) · Neurochemical Research · doi:10.1023/a:1022557920150 · Cited by 44
Alzheimer's Disease Amyloid β Peptide 25-35 Inhibits Lipid Peroxidation as a Result of Its Membrane Interactions
Walter, M. F., Mason, P. E., & Mason, R. P. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6547 · Cited by 44
Evidence of oxidative stress-induced BNIP3 expression in amyloid beta neurotoxicity
Zhang, S., Zhang, Z., Sandhu, G., Ma, X., Yang, X., Geiger, J. D., & Kong, J. (2007) · Brain Research · doi:10.1016/j.brainres.2006.12.086 · Cited by 44
Effect of dietary supplementation of dates in Alzheimer's disease APPsw/2576 transgenic mice on oxidative stress and antioxidant status
Subash, S., Essa, M. M., Al-Asmi, A. R., Al‐Adawi, S., Vaishnav, R., & Guillemin, G. J. (2014) · Nutritional Neuroscience · doi:10.1179/1476830514y.0000000134 · Cited by 43
Metal Chelators Coupled with Nanoparticles as Potential Therapeutic Agents for Alzheimer's Disease
Liu, G., Men, P., Perry, G. L., & Smith, M. A. (2009) · Journal of Nanoneuroscience · doi:10.1166/jns.2009.005 · Cited by 43
Transgenic murine cortical neurons expressing human Bcl-2 exhibit increased resistance to amyloid β-peptide neurotoxicity
Saillé, C., Marin, P., Martinou, J., Nicole, A., London, J., & Ceballos-Picot, I. (1999) · Neuroscience · doi:10.1016/s0306-4522(99)00089-5 · Cited by 43
Demonstration of an anti‐oxidative stress mechanism of quetiapine
Xu, H., Wang, H., Zhuang, L., Yan, B., Yu, Y., Wei, Z., Zhang, Y., Dyck, L. E., Richardson, S. J., He, J., et al. (2008) · FEBS Journal · doi:10.1111/j.1742-4658.2008.06519.x · Cited by 42
Mechanistic and therapeutic role of Drp1 in the pathogenesis of Alzheimer's disease
Bera, A., Lavanya, G., Reshmi, R., Dev, K., & Kumar, R. K. (2022) · European Journal of Neuroscience · doi:10.1111/ejn.15611 · Cited by 43
Dehydroepiandrosterone reduces expression and activity of BACE in NT2 neurons exposed to oxidative stress
Tamagno, E., Guglielmotto, M., Bardini, P., Santoro, G., Davit, A., Simone, D. D., Danni, O., & Tabaton, M. (2003) · Neurobiology of Disease · doi:10.1016/s0969-9961(03)00131-1 · Cited by 42
Theoretical study on the peroxyl radicals scavenging activity of esculetin and its regeneration in aqueous solution
Medina, M. E., Galano, A., & Alvarez-Idaboy, J. R. (2013) · Physical Chemistry Chemical Physics · doi:10.1039/c3cp53889c · Cited by 42
Amyloid β-peptide(1–40)-mediated oxidative stress in cultured hippocampal neurons
Aksenov, M. Y., Aksenova, M. V., Markesbery, W. R., & Butterfield, D. A. (1998) · Journal of Molecular Neuroscience · doi:10.1007/bf02761773 · Cited by 42
Self-citation
Nicotine and its interaction with β-amyloid protein: a short review
Zamani, R., & Allen, Y. S. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(00)01108-2 · Cited by 42
Retinoic acid isomers protect hippocampal neurons from amyloid-β induced neurodegeneration
Sahin, M., Karaüzüm, S. B., Perry, G., Smith, M. A., & Alicigüzel, Y. (2005) · Neurotoxicity Research · doi:10.1007/bf03036453 · Cited by 41
Calmodulin antagonizes amyloid-β peptides-mediated inhibition of brain plasma membrane Ca2+-ATPase
Berrocal, M., Sepúlveda, M. R., Vázquez-Hernández, M., & Mata, A. M. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.02.013 · Cited by 41
Antioxidant activity of fraxetin and its regeneration in aqueous media. A density functional theory study
Medina, M. E., Iuga, C., & Alvarez-Idaboy, J. R. (2014) · RSC Advances · doi:10.1039/c4ra08394f · Cited by 42
A Direct Interaction Between Mitochondrial Proteins and Amyloid-β Peptide and its Significance for the Progression and Treatment of Alzheimer’s Disease
Benek, O., Aitken, L., Hroch, L., Kuča, K., Gunn‐Moore, F. J., & Musílek, K. (2015) · Current Medicinal Chemistry · doi:10.2174/0929867322666150114163051 · Cited by 41
On the Outstanding Antioxidant Capacity of Edaravone Derivatives through Single Electron Transfer Reactions
Pérez‐González, A., & Galano, A. (2011) · The Journal of Physical Chemistry B · doi:10.1021/jp209930y · Cited by 41
Aging, gender and APOE isotype modulate metabolism of Alzheimer's Aβ peptides and F2‐isoprostanes in the absence of detectable amyloid deposits
Yao, J., Petanceska, S. S., Montine, T. J., Holtzman, D. M., Schmidt, S. D., Parker, C. A., Callahan, M. J., Lipinski, W. J., Bisgaier, C. L., Turner, B. A., et al. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02532.x · Cited by 41
β-amyloid modulates tyrosine kinase B receptor expression in SHSY5Y neuroblastoma cells: influence of the antioxidant melatonin
Olivieri, G., Otten, U., Meier, F., Baysang, G., Dimitriades‐Schmutz, B., Müller-Spahn, F., & Savaskan, E. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00342-7 · Cited by 41
Tunable Plasmonic Cavity for Label-free Detection of Small Molecules
Kwon, J. A., Jin, C. M., Shin, Y., Kim, H. Y., Kim, Y., Kang, T., & Choi, I. (2018) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.8b01550 · Cited by 42
Upregulation of iron regulatory proteins and divalent metal transporter-1 isoforms in the rat hippocampus after kainate induced neuronal injury
Huang, E., Ong, W.-Y., Go, M., & Connor, J. R. (2005) · Experimental Brain Research · doi:10.1007/s00221-005-0220-x · Cited by 40
Astrocytes contain amyloid-β annular protofibrils in Alzheimer's disease brains
Lasagna‐Reeves, C. A., & Kayed, R. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.08.027 · Cited by 41
Overexpression of aldehyde dehydrogenase 1A1 reduces oxidation‐induced toxicity in SH‐SY5Y neuroblastoma cells
Zhang, M., Shoeb, M., Goswamy, J., Liu, P., Xiao, T., Hogan, D., Campbell, G. A., & Ansari, N. H. (2009) · Journal of Neuroscience Research · doi:10.1002/jnr.22230 · Cited by 40
Metallostasis and amyloid β-degrading enzymes
Grasso, G., Giuffrida, M. L., & Rizzarelli, E. (2012) · Metallomics · doi:10.1039/c2mt20105d · Cited by 41
Generation of reactive oxygen species and activation of NF‐κB by non‐Aβ component of Alzheimer's disease amyloid
Tanaka, S., Takehashi, M., Matoh, N., Iida, S., Suzuki, T. W., Futaki, S., Hamada, H., Masliah, E., Sugiura, Y., & Ueda, K. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00958.x · Cited by 40
The antioxidant enzymatic blood profile in Alzheimer's and vascular diseases. Their association and a possible assay to differentiate demented subjects and controls
Famulari, A. L., Marschoff, E. R., Llesuy, S., Kohan, S., Serra, J. A., Domínguez, R. O., Repetto, M. G., Reides, C. G., & de Lustig, E. S. (1996) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(96)00163-3 · Cited by 40
Modulation of Glutamine Synthesis in Cultured Astrocytes by Nitric Oxide
Miñana, M., Kosenko, E. A., Marcaida, G., Hermenegildo, C., Montoliu, C., Grisolía, S., & Felipo, V. (1997) · Cellular and Molecular Neurobiology · doi:10.1023/a:1026339428059 · Cited by 40
Metabolic Modifications in Human Biofluids Suggest the Involvement of Sphingolipid, Antioxidant, and Glutamate Metabolism in Alzheimer’s Disease Pathogenesis
Ellis, B., Hye, A., & Snowden, S. G. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-141899 · Cited by 39
Connecting the Dots: Macromolecular Crowding and Protein Aggregation
Siddiqui, G. A., & Naeem, A. (2022) · Journal of Fluorescence · doi:10.1007/s10895-022-03082-2 · Cited by 39
Detection of Oxidative Base DNA Damage by a New Biochemical Assay
Sattler, U. G. A., Calsou, P., Boiteux, S., & Salles, B. (2000) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.2000.1701 · Cited by 39
Cerebral T2-Weighted Signal Decrease During Aging in the Mouse Lemur Primate Reflects Iron Accumulation
Dhénain, M., Duyckaerts, C. J., Michot, J., Volk, A., Picq, J., & Boller, F. (1998) · Neurobiology of Aging · doi:10.1016/s0197-4580(98)00005-0 · Cited by 39
Cellular Cofactors for Amyloid β-Peptide-Induced Cell Stress
Yan, S. D., Roher, A. E., Schmidt, A. M., & Stern, D. M. (1999) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65452-1 · Cited by 40
Highly Sensitive Colorimetric Detection and Facile Isolation of Diamagnetic Free Radical Adducts of Novel Chromotropic Nitrone Spin Trapping Agents Readily Derived from Guaiazulene
Becker, D. A. (1996) · Journal of the American Chemical Society · doi:10.1021/ja952895z · Cited by 39
α-1-Antichymotrypsin interaction with Aβ (1–40) inhibits fibril formation but does not affect the peptide toxicity
Aksenova, M. V., Aksenov, M. Y., Butterfield, D. A., & Carney, J. M. (1996) · Neuroscience Letters · doi:10.1016/0304-3940(96)12717-8 · Cited by 39
Self-citation
Free radicals and lipid peroxidation do not mediate β-amyloid-induced neuronal cell death
Yao, Z., Drieu, K., Szweda, L. I., & Papadopoulos, V. (1999) · Brain Research · doi:10.1016/s0006-8993(99)02047-8 · Cited by 39
Potentiation of beta-folding of β-amyloid peptide 25–35 by aluminum salts
Bondy, S. C., & Truong, A. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00307-9 · Cited by 39
Theoretical study on the chemical fate of adducts formed through free radical addition reactions to carotenoids
Martı́nez, A., Vargas, R., & Galano, A. (2010) · Theoretical Chemistry Accounts · doi:10.1007/s00214-010-0753-3 · Cited by 38
The neuritogenic and neuroprotective potential of senegenin against Aβ-induced neurotoxicity in PC 12 cells
Jesky, R., & Chen, H. (2015) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-016-1006-3 · Cited by 38
Recent Insights on Alzheimer’s Disease Originating from Yeast Models
Seynnaeve, D., Vecchio, M. D., Fruhmann, G., Verelst, J., Cools, M., Beckers, J., Mulvihill, D. P., Winderickx, J., & Franssens, V. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19071947 · Cited by 39
Study of the non‐covalent interaction between amyloid‐β‐peptide and melatonin using electrospray ionization mass spectrometry
Bazoti, F. N., Tsarbopoulos, A., Markides, K. E., & Bergquist, J. (2005) · Journal of Mass Spectrometry · doi:10.1002/jms.738 · Cited by 38
Alzheimer's amyloid-beta peptide inhibits sodium/calcium exchange measured in rat and human brain plasma membrane vesicles
Wu, A., D’Errico, C., Hatem, L., & Colvin, R. A. (1997) · Neuroscience · doi:10.1016/s0306-4522(97)00053-5 · Cited by 38
Effects of mitochondrial respiratory stimulation on membrane lipids and proteins: an electron paramagnetic resonance investigation
Gabbita, S. P., Subramaniam, R., Allouch, F., Carney, J. M., & Butterfield, D. A. (1998) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(98)00040-6 · Cited by 38
Self-citation
Calcium Homeostasis and Free Radical Metabolism as Convergence Points in the Pathophysiology of Dementia
Mattson, M. P., Furukawa, K., Bruce‐Keller, A. J., Mark, R. J., & Blanc, E. M. (1997) · Humana Press eBooks · doi:10.1007/978-1-59259-471-9_8 · Cited by 38
Self-citation
Energy, oxidative damage, and Alzheimer's disease: Clues to the underlying puzzle
Beal, M. F. (1994) · Neurobiology of Aging · doi:10.1016/0197-4580(94)90198-8 · Cited by 38
Cerium Oxide Nanoparticles for the Treatment of Neurological Oxidative Stress Diseases
Estevez, A. Y., & Erlichman, J. S. (2011) · ACS symposium series · doi:10.1021/bk-2011-1083.ch009 · Cited by 37
Protein Glutathionylation and Glutaredoxin: Role in Neurodegenerative Diseases
Haseena, P. A., Diwakar, L., & Ravindranath, V. (2022) · Antioxidants · doi:10.3390/antiox11122334 · Cited by 37
Amyloid β peptides and central cholinergic neurons: functional interrelationship and relevance to Alzheimer's disease pathology
Kar, S., & Quirion, R. (2004) · Progress in brain research · doi:10.1016/s0079-6123(03)45018-8 · Cited by 37
Effects of Amyloid β-Peptides on the Lysis Tension of Lipid Bilayer Vesicles Containing Oxysterols
Kim, D. H., & Frangos, J. A. (2008) · Biophysical Journal · doi:10.1529/biophysj.107.114983 · Cited by 37
Molecular Neurobiology of Alzheimer's Disease (Syndrome?)
Zubenko, G. S. (1997) · Harvard Review of Psychiatry · doi:10.3109/10673229709000303 · Cited by 37
Up-regulation of Bcl-xL in response to subtoxic β-amyloid: role in neuronal resistance against apoptotic and oxidative injury
Luetjens, C. M., Lankiewicz, S., Bui, N. T., Krohn, A. J., Poppe, M., & Prehn, J. H. M. (2001) · Neuroscience · doi:10.1016/s0306-4522(00)00458-9 · Cited by 37
Gossypin protects primary cultured rat cortical cells from oxidative stress- and β-amyloid-lnduced toxicity
Yoon, I., Lee, K. H., & Cho, J. (2004) · Archives of Pharmacal Research · doi:10.1007/bf02980089 · Cited by 37

Authors: Hensley, K., Carney, J. M., Mattson, M. P., Aksenova, M., Harris, M., Wu, J. F., Floyd, R. A., & Butterfield, D. A.
Affiliations: University of Kentucky (US)
Department of Chemistry, University of Kentucky, Lexington 40506.
ORCID: Mattson, M P
Aksenova, M
Butterfield, D A
Venue: Proceedings of the National Academy of Sciences
Publisher: National Academy of Sciences
Published: 1994-04-12
Volume: 91
Issue: 8
Pages: 3270-3274
ISSN: 0027-8424 (ISSN-L)
1091-6490
DOI: 10.1073/pnas.91.8.3270
PMC: PMC43558
OpenAlex: W2070117026
Cited by: 1,086
References: 23
Citations by year: 2026: 6 · 2025: 12 · 2024: 20 · 2023: 16 · 2022: 21 · 2021: 26 · 2020: 15 · 2019: 18 · 2018: 26 · 2017: 15 · 2016: 23 · 2015: 27 · 2014: 26 · 2013: 32 · 2012: 34
FWCI: 35.21
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Locations: Proceedings of the National Academy of Sciences (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: National Science Foundation (9108764)
Glenn Foundation for Medical Research
Fondation pour la Recherche Médicale
National Institutes of Health (AG-10836)
National Institute on Aging (AG 09690, P01AG010836, R01AG009690, AG 10836)
Office of Naval Research
National Institute of Neurological Disorders and Stroke (R01NS023307, NS-23307)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Prion Diseases and Protein Misfolding
Keywords: amyloid-beta, amyloid fibril formation, neurotoxicity, free radicals, reactive oxygen species, glutamine synthetase, creatine kinase, salicylate hydroxylation, amyloid plaques, Alzheimer's disease, peptide fragmentation, membrane alterations
MeSH terms: Alzheimer Disease, Amino Acid Sequence, Chromatography, High Pressure Liquid, Electron Spin Resonance Spectroscopy, Free Radicals, Gas Chromatography-Mass Spectrometry, Molecular Sequence Data, Neurotoxins, Salicylates, Amyloid beta-Peptides

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease.

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks